Immunologic induction of reticulum cell sarcoma donor-type lymphomas in the graft-versus-host model


  • PubMed  status
    (0) (0 Votes)
    Views: (1026)  
    Date:
    (13-12-08)  
    Pages:
    ()
  • Author:  Gleichmann E, Peters K, Lattmann E, Gleichmann H.

  • Abstract:The aim of this study was to investigate malignant lymphomas of donor origin induced in F1 mice undergoing a chronic graft-versus-host reaction (GVHR) after injection of parental strain spleen cells. A total of 3 X 10(8) or 4 X 10(8) C57BL/10 spleen cells were administered to 7-8-week-old H-2 incompatible (C57BL/10 X HTG)F1 hybrids either as single or fractionated i.p. injections. Recipients were killed at intervals ranging from 1 month to 1 year after the first injection and their lymphoid cells typed for host-derived and donor-derived histocompatibility antigens. In 49% of the 88 GVH F1 mice, cells failed to be killed by a hyperimmune serum against HTG (H-2g) but reacted normally with antisera to C57BL/10 (H-2b) and, in the 9 cases tested, to theta-C3H. The conclusion that the lymphoid cells of these mice were derived from donor cells was supported by the finding that these animals lacked immunoglobulins bearing host-derived Iga allotype in their serum. Forty-three percent of the GVH F1 mice developed reticulum cell sarcomas (RCS), 32% revealed hyperplastic lymphoreticular tissue, and 25% showed no grossly abnormal changes. Mice with donor-type lymphoid tissues were found in all three groups; 50% of the 38 RCS detected were donor-type neoplasms. The induction of donor-type RCS during the GVHR strengthens the concept of lymphomagenesis through persistent stimulation with antigen(s).

Write a Comment


     Related Documents
Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantati...
Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantati...
Drug interactions involving immunologic agents Part II Immunodiagnostic and other immunolo...
  • Drug interactions involving immunologic agents Part II Immunodiagnostic and othe...

  • Drug interactions involving immunologic agents. Part II. Immunodiagnostic and other immunologic drug interactions. Grabenstein JD. Pharmacy Service, U.S. Army Hospital-Bremerhaven, West Germany. This two-part review addresses pharmacists' need for information about immunologic drug interactions. Reports of interactions involving vaccines, immune globulins, and immunodiagnostic reagents are widely dispersed and, therefore, difficult to access. In the conclusion of this two-part article, immunodiagnostic drug interactions as well as interactio...

 Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia II Studies of...
  • Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia II ...

  • [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. II. Studies of immunologic phenotype of peripheral blood and lymph node lymphocytes in patients with chronic lymphocytic leukemia or leukemic forms of lymphoplasmacytoid lymphoma] [Article in Polish] Rupniewska ZM, Rozynkowa D, Antosz H, Kowal M, Wach M, Rolinski J. Kliniki Hematologii AM, Lublinie. In a group of 16 patients with chronic lymphocytic leukaemia and leukaemic forms of the lymphoma lymphoplasmocytoides immunophenotypes of peripheral blood and lymp...

 Immunologic changes in polytransfused hemophiliacs
  • Immunologic changes in polytransfused hemophiliacs

  • [Immunologic changes in polytransfused hemophiliacs] [Article in Italian] Gamba G. Dipartimento di Medicina Interna e Terapia Medica, Universit? di Pavia, IRCCS Policlinico San Matteo. PMID: 1752541 [PubMed - indexed for MEDLINE]

 History of immunologic deficiency
  • History of immunologic deficiency

  • [History of immunologic deficiency] [Article in Italian] Corbellini G, Ribatti D. Dipartimento di Genetica e Biologia molecolare, Facolt? di Scienze matematiche, fisiche e naturali, Universit? La Sapienza, Roma. The description of agammaglobulinemia by O. Bruton in 1952 and later clinical studies by R. Good preceeded by sporadic clinical observations on deficits in the immune function associated with hyponutrition, nephrosis and tumors or with inborn errors of metabolism have all made their contribution to the emerging of the concept of...

Immunologic aspects of pneumoconiosis
  • Immunologic aspects of pneumoconiosis

  • Immunologic aspects of pneumoconiosis. Scheule RK, Holian A. Department of Pharmacology, University of Texas Medical School, Houston 77030. This review summarizes recent research bearing on the role played by cells of the immune system in the development of pneumoconiosis. Findings related to the cellular and humoral immune responses to silica and asbestos are highlighted. Experimental results from humans and animal models are integrated into our current understandings of cellular and cytokine-mediated pathways leading to the generation of i...

Immunologic associations of keloids
  • Immunologic associations of keloids

  • Immunologic associations of keloids. Placik OJ, Lewis VL Jr. Department of Surgery, Northwestern University Medical School, Chicago, Illinois. The mechanisms underlying the pathogenesis of keloids have not been fully characterized despite extensive past and present research. Results of past and present studies have shown that the immune system is actively involved in the development of these lesions. Future investigations into the biochemistry and immunologic factors of keloids are anticipated and expected to produce additional insight. The ...

 Immunologic sperm detection
  • Immunologic sperm detection

  • [Immunologic sperm detection] [Article in German] M?ller V, Hinkelmann G. Institut f?r Rechtsmedizin, Universit?t W?rzburg. Proof of prostatic acid phosphatase with the enzyme-immuno-assay (EIA) is specific and as sensitive as the common phosphatase reaction. The EIA for prostatic-specific-antigen (PSA) is prostate specific as well, but less sensitive than the phosphatase assay. In a review of 30 own cases no indications for nonspecifity of the immuno assay were obtained. A positive EIA-test in absence of spermatozoa can be explained by...

 Immunologic aspects of endometriosis
  • Immunologic aspects of endometriosis

  • [Immunologic aspects of endometriosis] [Article in German] Meisel M, Straube W. Klinik und Poliklinik f?r Gyn?kologie und Geburtshilfe, Ernst-Moritz-Arndt-Universit?t Greifswald. In development of endometriosis immunological phenomenons are discussed. In women with endometriosis specific antibodies are demonstrated and it is worth to speculate that there takes place de novo-expression of specific antigens. It is also possible, that changes in humoral immunity in endometriosis are secondary to deficient cellular mechanisms. PMID: 162643...


  •       > LOGIN OR SIGN UP FOR FREE NOW!




         Related Videos

         Related Groups
    Immunologic adjuvant
    Immunologic activation

         Embed on a Website/Blog
    • URL:




























     

    Powered free by PHPmotion